Differential regulation of three catalytic activities of platelet-activating factor (PAF)-dependent transacetylase

被引:6
|
作者
Lee, TC [1 ]
Malone, B
Longobardi, L
Balestrieri, ML
机构
[1] Oak Ridge Associated Univ, Basic & Appl Res Unit, Oak Ridge, TN 37831 USA
[2] Univ Naples 2, Dept Biochem & Biophys F Cedrangolo, I-80138 Naples, Italy
关键词
platelet-activating factor; transacetylase; acetylhydrolase; C-2-ceramide; analogs of PAF;
D O I
10.1006/abbi.2000.2226
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We have previously established that PAF-dependent transacetylase (TA) purified to apparent homogeneity from rat kidney membranes and cytosol contains three separate catalytic activities, namely PAF lysophospholipid transacetylase (TA(1)), PAF sphingosine transacetylase (TA(s)), and PAF acetylhydrolase (AH), In the present investigation, we studied the biochemical factors and mechanism(s) that differentially regulate these three TA activities of the purified enzymes. We found that only the TA(s) activity of the TA purified from the membranes was stimulated by phosphatidylserine (PS) with optimal concentration of activation occurring at 25 muM, Other acidic phospholipids, such as phosphatidylinositol (PI) and phosphatidylinositol I-phosphate (PIP), are partially effective, while diacylglycerol and free fatty acids had no effect on the TA(s) activity. PS exerted its effect on the TA(s) activity through the increases of both K-m and V-max. In addition, N-ethylmalimide (NEM) and dithiobis-(2-nitro-5-thiobenzoic acid) (DTNB) strongly inhibited the TA(L) activity and partially decreased the TA(L) and AH activities of the purified membrane enzyme in a dose-dependent manner. The addition of PS, but not by its substrate, sphingosine, could prevented the inhibition by NEM on the basal level of TA(s). On the other hand, the inhibition of TAL by NEM and DTNB were partially protected by the substrate, lysoplasmalogens, Furthermore, PAF fully protects the inhibition of AH, partially protects the inhibition of TA(L), and does not protect the inhibition of TA(s) by NEM, These results suggested that the three individual catalytic activities of TA have different dependencies on the thiol-containing residue(s) of the enzyme, i.e., cysteine. Furthermore, the nonresponsiveness of the purified cytosolic TA(s) to PS activation is consistent with our previous notions that membrane and cytosolic TA are posttranslationally distinct. (C) 2001 Academic Press.
引用
收藏
页码:41 / 46
页数:6
相关论文
共 50 条
  • [1] A SPECIFIC, SENSITIVE RADIOIMMUNOASSAY FOR PLATELET-ACTIVATING FACTOR (PAF)
    SMAL, MA
    BALDO, BA
    MCCASKILL, A
    JOURNAL OF IMMUNOLOGICAL METHODS, 1990, 128 (02) : 183 - 188
  • [2] Platelet-activating factor and cardiac diseases: Therapeutic potential for PAF inhibitors
    Feuerstein, G
    Rabinovici, R
    Leor, J
    Winkler, JD
    Vonhof, S
    JOURNAL OF LIPID MEDIATORS AND CELL SIGNALLING, 1997, 15 (03): : 255 - 284
  • [3] The actions,detection and synthesis of platelet-activating factor (PAF) in mammalian pregnancy
    刘玉堂
    隋淑芹
    孙中武
    毕冰
    许翠清
    JournalofForestryResearch, 1998, (04) : 283 - 287
  • [4] The actions, detection and synthesis of platelet-activating factor (PAF) in mammalian pregnancy
    Liu Yutang
    Sui Shuqin
    Sun Zhongwu
    Bi Bing
    Xu Cuiqing
    Journal of Forestry Research, 1998, 9 (4) : 283 - 287
  • [5] EFFECT OF PLATELET-ACTIVATING FACTOR (PAF) AND SYNTHETIC ANALOGS ON FIBRINOLYSIS IN RATS
    HOFMANN, B
    MEISGEIER, U
    GREINER, J
    KERTSCHER, HP
    OSTERMANN, G
    FIBRINOLYSIS, 1990, 4 (04) : 247 - 252
  • [6] Platelet-Activating Factor (PAF) in Allergic Rhinitis: Clinical and Therapeutic Implications
    Munoz-Cano, Rosa M.
    Casas-Saucedo, Rocio
    Valero Santiago, Antonio
    Bobolea, Irina
    Ribo, Paula
    Mullol, Joaquim
    JOURNAL OF CLINICAL MEDICINE, 2019, 8 (09)
  • [7] Platelet-activating factor (PAF)-like oxidized phospholipids: Relevance to atherosclerosis
    Tokumura, A
    Sumida, T
    Toujima, M
    Kogure, K
    Fukuzawa, K
    BIOFACTORS, 2000, 13 (1-4) : 29 - 33
  • [8] Lysophosphatidylcholine (LPC) induces proinflammatory cytokines by a platelet-activating factor (PAF) receptor-dependent mechanism
    Huang, YH
    Schäfer-Elinder, L
    Wu, R
    Claesson, HE
    Frostegård, J
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1999, 116 (02): : 326 - 331
  • [9] Regulation of the biosynthesis of acyl analogs of platelet-activating factor by purinergic agonist in endothelial cells
    Balestrieri, ML
    Lee, TC
    FEBS LETTERS, 2000, 479 (1-2) : 63 - 66
  • [10] Mammalian platelet-activating factor acetylhydrolases
    Stafforini, DM
    Prescott, SM
    Zimmerman, GA
    McIntyre, TM
    BIOCHIMICA ET BIOPHYSICA ACTA-LIPIDS AND LIPID METABOLISM, 1996, 1301 (03): : 161 - 173